Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1–84) treatment

PURPOSE: The main purpose of this study was to investigate the effects of 12 months of rhPTH (1–84) (Natpar(®)) treatment in a cohort of patients selected according to the indications of hypoparathyroidism guidelines. The use of recombinant human PTH (1–84) [rhPTH (1–84)] is approved as hormonal rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcucci, G., Beccuti, G., Carosi, G., Cetani, F., Cianferotti, L., Colao, A. M., Di Somma, C., Duradoni, M., Elefante, A., Ghizzoni, L., Giusti, M., Lania, A. G., Lavezzi, E., Madeo, B., Mantovani, G., Marcocci, C., Masi, L., Parri, S., Pigliaru, F., Santonati, A., Spada, A., Vera, L., Brandi, M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360119/
https://www.ncbi.nlm.nih.gov/pubmed/35460461
http://dx.doi.org/10.1007/s40618-022-01800-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360119/
https://www.ncbi.nlm.nih.gov/pubmed/35460461
http://dx.doi.org/10.1007/s40618-022-01800-y

Ejemplares similares